Attached files
| file | filename |
|---|---|
| 8-K - CURRENT REPORT - OptimizeRx Corp | ea123477-8k_optimizerx.htm |
Exhibit 16.1
June 26, 2020
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Commissioners:
We have read the statements made by OptimizeRx Corporation under Item 4.01 of its Form 8-K dated June 22, 2020. We agree with the statements concerning our Firm in such Form 8-K; we are not in a position to agree or disagree with other statements of OptimizeRx Corporation contained therein.
Very truly yours,
/s/ Marcum LLP
Marcum LLP